1st Quarter - Report — TODD STRATEGY GROUP for GENENTECH, INC. (2021)

Firm

TODD STRATEGY GROUP

Client

GENENTECH, INC.

Income

$60,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

COVID-19 Response.

Lobbyist	Covered position, as disclosed
PAUL EDATTEL	—
DANIEL M TODD	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Medicare and Medicaid payment issues. Home infusion. 340B issues.

Lobbyist	Covered position, as disclosed
PAUL EDATTEL	Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
DANIEL M TODD	Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & Medicaid

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Prescription drug payment reform. Supply chain. Strategic National Stockpile.

Lobbyist	Covered position, as disclosed
PAUL EDATTEL	—
DANIEL M TODD	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.